Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-19 Sale |
2024-01-19 6:25 pm |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
12,900 | $1.28 | $16,512 | 584,662 (Direct) |
View |
2023-01-19 Sale |
2023-01-20 4:29 pm |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
14,030 | $1.5 | $21,045 | 363,472 (Direct) |
View |
2022-01-19 Sale |
2022-01-20 7:07 pm |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
8,833 | $2.09 | $18,461 | 482,616 (Direct) |
View |
2021-09-21 Sale |
2021-09-23 5:12 pm |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
2,800 | $6.41 | $17,948 | 316,449 (Direct) |
View |
2021-06-21 Sale |
2021-06-23 5:42 pm |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
2,938 | $4.37 | $12,839 | 319,249 (Direct) |
View |
2020-06-01 Sale |
2020-06-03 4:43 pm |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
14,992 | $1.88 | $28,185 | 220,827 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-08 Option Award |
2025-01-10 4:30 pm |
N/A 2035-01-08 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
2024-01-18 Option Award |
2024-01-19 6:25 pm |
N/A 2034-01-18 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
200,000 | $0 | 584,662 (Direct) |
View |
2023-09-18 Option Award |
2023-09-20 4:30 pm |
N/A 2033-09-18 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2023-09-13 Exercise |
2023-09-13 6:55 pm |
N/A 2023-11-24 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
34,090 | $0 | 397,562 (Direct) |
View |
2023-09-13 Exercise |
2023-09-13 6:55 pm |
N/A N/A |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
34,090 | $0.4 | 397,562 (Direct) |
View |
2023-01-04 Option Award |
2023-01-06 4:28 pm |
N/A 2033-01-04 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
187,500 | $0 | 187,500 (Direct) |
View |
2022-12-20 Exercise |
2022-12-20 4:38 pm |
N/A 2023-02-28 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
23,636 | $0 | 377,502 (Direct) |
View |
2022-12-20 Exercise |
2022-12-20 4:38 pm |
N/A N/A |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
23,636 | $0.4 | 377,502 (Direct) |
View |
2022-01-18 Option Award(A) |
2022-01-28 4:51 pm |
N/A 2032-01-18 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
185,000 | $0 | 501,449 (Direct) |
View |
2022-01-18 Option Award |
2022-01-20 7:07 pm |
N/A 2032-01-18 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
175,000 | $0 | 482,616 (Direct) |
View |
2021-01-18 Option Award |
2021-01-20 6:18 pm |
N/A 2031-01-18 |
Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer |
292,000 | $0 | 517,827 (Direct) |
View |